Buy, hold, sell: BHP, CSL, and Woodside shares

Let's see if analysts are bullish or bearish on these giants.

| More on:

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More

There are a lot of blue-chip ASX 200 shares to pick from on the Australian share market.

But not all are necessarily buys right now.

So, to narrow things down, let's see what analysts are saying about three of the most popular shares on the ASX 200 index. Here's what you need to know:

A man casually dressed looks to the side in a pensive, thoughtful manner with one hand under his chin, and holding a mobile phone in his other hand.

Image source: Getty Images

BHP Group Ltd (ASX: BHP)

BHP is the world's largest mining company and a major producer of commodities such as iron ore, copper, and metallurgical coal.

One positive currently working in its favour is the strength in copper prices. Copper is widely viewed as one of the most important commodities for electrification, renewable energy infrastructure, and electric vehicles. With demand expected to rise strongly over the coming decade, BHP's significant exposure to copper could become an increasingly valuable part of its portfolio.

But does this make BHP shares a buy?

Morgan Stanley has an overweight rating on the mining giant with a $56.00 price target. Meanwhile, Ord Minnett has an accumulate rating with a $54.00 price target. This compares favourably to the current BHP share price of $49.39.

CSL Ltd (ASX: CSL)

CSL is one of Australia's largest healthcare companies and a global leader in plasma therapies, vaccines, and biotechnology products.

Unlike some other ASX heavyweights, CSL has not enjoyed much positive momentum recently. Its shares have come under significant pressure and are trading well below their historical highs, which has left the company looking relatively cheap compared to its long-term valuation.

Is this an opportunity to buy a high-quality healthcare business with global operations, a large research pipeline, and strong positions in specialised treatment markets?

Despite its struggles, brokers remain positive on CSL and see value in its shares. Morgans has a buy rating on the healthcare giant with a $241.34 price target, while UBS also has a buy rating and a $235.00 price target. This compares to the current CSL share price of $139.86.

Woodside Energy Group Ltd (ASX: WDS)

Woodside is Australia's largest oil and gas producer and generates the bulk of its earnings from global energy markets.

One of the major positives currently supporting the company is the strength in oil prices, which are trading above US$100 per barrel due to the war in the Middle East. Higher oil prices typically translate into stronger cash flow for energy producers, which can support dividends and investment in new projects.

Does this make Woodside shares a buy?

Well, due to recent share price strength, brokers are largely on the fence with this one. UBS currently has a neutral (hold) rating on the company with a $28.10 price target, while Macquarie also has a neutral rating with a $30.00 price target. This compares to the current Woodside share price of $31.51.

Motley Fool contributor James Mickleboro has positions in CSL and Woodside Energy Group Ltd. The Motley Fool Australia's parent company Motley Fool Holdings Inc. has positions in and has recommended CSL and Macquarie Group. The Motley Fool Australia has positions in and has recommended Macquarie Group. The Motley Fool Australia has recommended BHP Group and CSL. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.

More on Broker Notes

A graphic image of a pile of gold coins balanced precariously with a house on top with smoke coming out of the chimney and a human figure with hands up as if to shield himself from the prospect of the house falling.
Broker Notes

This debt collector could surge 47% on negative gearing changes, Shaw and Partners says

A weaker housing market could be a boon for this company.

Read more »

Three young nerds dressed in suits with thinking caps and lightbulbs
Broker Notes

Brokers name 3 ASX shares to buy right now

Let's find out which shares top brokers are feeling bullish about this week.

Read more »

A woman in a red dress holding up a red graph.
Broker Notes

4 ASX shares Macquarie says could return more than 40%

The broker has made some bold predictions.

Read more »

A woman leans forward with her hand behind her ear, as if trying to hear information.
Broker Notes

Down 60%, are Cochlear shares now a bargain buy?

A leading analyst provides his outlook for Cochlear’s beaten-down shares.

Read more »

A businessman hugs his computer and smiles.
Broker Notes

Why this ASX stock is a 'compelling value play'

Value investors might want to check out this share that Bell Potter is bullish on.

Read more »

Man holding a calculator with Australian dollar notes, symbolising dividends.
Broker Notes

Should I buy Rio Tinto shares for passive income?

A leading analyst provides his outlook for Rio Tinto shares and dividends.

Read more »

Woman with her fingers crossed and eyes shut.
Broker Notes

4 ASX shares upgraded by brokers this week

Brokers have new confidence in TPG Telecom, Deep Yellow, and other stocks this week.

Read more »

Three adorable children sit side by side at a table wearing upturned colanders on their heads fixed with shining light bulbs as they smile at the camera.
Broker Notes

Buy, hold, sell: Nick Scali, Nyrada, Wesfarmers shares

Experts reveal their ratings on three ASX shares in the retail and biotech segments. 

Read more »